CLINICAL TRIALS PROFILE FOR HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
✉ Email this page to a colleague
All Clinical Trials for hydrochlorothiazide; metoprolol succinate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00642096 ↗ | Factorial Study of Metoprolol Succinate TOPROL-XL (324A) | Completed | AstraZeneca | Phase 3 | 2003-06-01 | The purpose of this research study is to determine if treatment with the combination of metoprolol succinate and hydrochlorothiazide is more effective at lowering blood pressure than treatment with either of the two drugs alone. The study will also determine which combined doses of metoprolol succinate and hydrochlorothiazide are most effective at lowering blood pressure (without unacceptable side effects), and whether it is possible to combine both drugs in a single tablet to simplify blood pressure treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for hydrochlorothiazide; metoprolol succinate
Condition Name
Clinical Trial Progress for hydrochlorothiazide; metoprolol succinate
Clinical Trial Phase
Clinical Trial Sponsors for hydrochlorothiazide; metoprolol succinate
Sponsor Name